Diagnosis and treatment of malignant skin tumors (Electronic educational course, 36 hours )
Audience category: doctors-specialists in the areas of training "Oncology»
Form of training: part-time.
Skin neoplasms are a heterogeneous group of diseases consisting of skin tumors, nevi, secondary metastatic tumors, and specific hemoderma. In our course, we will consider the most dangerous malignant skin formations.
Skin melanoma is a highly malignant mesenchymal tumor with an aggressive clinical course, developing from melanocytes (pigment cells that produce melanin). The incidence of skin melanoma in the developed countries of the world and the Russian Federation increases annually, by about 5% per year. According to WHO, the global incidence of skin melanoma will increase by 25% by 2025. According to the absolute increase in the incidence of malignant tumors in the world, melanoma ranks 2nd after lung cancer. According to studies conducted in the United States, 1 person dies from melanoma every hour.
Melanoma is the cause of 80% of deaths in the group of patients with skin malignancies. Unfortunately, in the Russian Federation, during the initial treatment to an oncologist, skin melanoma, in 25% of cases, is detected at the already advanced stages III-IV of the tumor process.
Malignant skin tumors (skin cancer + skin melanoma) in 2015 in the Russian Federation took the 1st place among the adult population (both sexes). The incidence of skin cancer among the adult population in the world and in Russia is steadily increasing. Basal cell carcinoma is the most common malignant skin tumor and accounts for 80% of them. This type of cancer is mainly localized on the skin of the head, face and neck.
With the introduction of the dermatoscopy method into the routine practice of medical specialists, the early diagnosis of skin melanoma and skin cancer and their precursors has improved somewhat. In recent years, diagnostic methods have been improved and treatment methods for skin melanoma at all stages of the tumor process have been optimized.
The above facts clearly prove the relevance of the continuous improvement of knowledge concerning malignant skin tumors. In recent years, characterized by great socio-economic changes, scientific research continues to improve the results of treatment of cancer patients. Extensive experience has been gained in the use of fundamentally new approaches to surgical, combined and complex treatment of skin cancer patients, which have significantly improved the 5-year survival rate of patients.
As part of the course, we:
1. We will tell you about the principles of early diagnosis, precancerous diseases and differential diagnosis of malignant skin formations.
2. Discuss the diagnosis and treatment of skin cancer.
3. We will tell you the features of the treatment of skin melanoma and its localized forms.
4. We will discuss approaches to the diagnosis and treatment of Merkel's carcinoma.
5. We will tell you the basic principles of immunotherapy for malignant tumors.
6. We will tell you about the principles of surgical treatment and modern possibilities of reconstructive surgery for basal cell carcinoma of the scalp and neck.
7. We will discuss the epidemiology and risk factors for squamous cell carcinoma of the head and neck, the principles, methodology and general indications for radiation and chemoradiotherapy.
8. Let's talk about the drug therapy of localized and disseminated squamous cell carcinoma of the head and neck.
9. We will discuss the practical aspects of combined and complex treatment of squamous cell carcinoma of the head and neck.
10. Let's talk about the tactics of treatment of oropharyngeal cancer, regional metastases in cancer of the oropharynx-naso-larynx.
11. We will discuss the choice of the reconstruction method for cancer of the oral mucosa.
12. We will tell you about the diagnosis and treatment of non-epithelial malignant tumors of the jaws.
13. We will discuss the general principles of surgical treatment of head and neck tumors.
14. We will tell you about the features of the treatment of laryngeal cancer and salivary gland cancer.
15. We will discuss the differential diagnosis and treatment of rare tumors of the head and neck.
Speakers of the advanced training course:
- Sevil Bagaturovna Aliyeva, MD, Senior Researcher at the Blokhin National Research Medical Center of Oncology, Ministry of Health of the Russian Federation.
- Kropotov Mikhail Alekseevich, MD, Professor, surgeon-oncologist of the State Medical Institution of the Moscow State Medical Center named after A. S. Loginov DZM.
- Kristina V. Orlova, PhD, Senior Researcher of the Department of Oncodermatology of the N. N. Blokhin National Research Medical Center of Oncology of the Ministry of Health of the Russian Federation.
- Ilya Stanislavovich Romanov, MD, Professor, Associate Professor of the Department of Oncology of the Pirogov Russian National Research Medical University, oncologist, surgeon of the N. N. Blokhin National Research Medical Center of Oncology of the Ministry of Health of the Russian Federation.
- Igor V. Samoylenko, Ph. D., Oncologist, Senior Researcher at the N. N. Blokhin National Research Medical Center of Oncology, Ministry of Health of the Russian Federation.
- Titov Konstantin Sergeevich, MD, Head of the Department of Surgery and Oncology, Faculty of Continuing Medical Education, RUDN, Head of the Oncosurgical Department of Skin and Soft Tissue Tumors of the State Medical Institution of the Moscow State Medical Center named after A. S. Loginov, MD, oncologist, surgeon.
- Harkevich Galina Yurievna, PhD, oncologist, Leading Researcher at the Blokhin National Research Center of Oncology of the Ministry of Health of the Russian Federation.